Savara (SVRA) Asset Utilization Ratio (2013 - 2022)

Name: Savara (SVRA) Asset Utilization Ratio (2013 - 2022) | Business Quant
Creator: Business Quant

Savara (SVRA) reported Asset Utilization Ratio of 0.0 for Q1 2022, down 99.59% on a QoQ basis from 0.0 in Q4 2021.

Savara (SVRA) has 8 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2022.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 0.0 (changed N/A YoY) and the FY2020 annual result came in at 0.0, changed N/A from the prior year.
Asset Utilization Ratio declined to 0.0 in Q1 2022 per SVRA's latest filing, from 0.0 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.0 in Q4 2020 and bottomed at 0.0 in Q1 2022.
The 3-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.0.
Peak annual rise in Asset Utilization Ratio reached 7.19% in 2021, while the deepest fall reached 43.09% in 2021.
Tracing SVRA's Asset Utilization Ratio over 3 years: stood at 0.0 in 2020, then plunged by 43.09% to 0.0 in 2021, then sank by 99.59% to 0.0 in 2022.
Per Business Quant, the three latest SVRA Asset Utilization Ratio figures stand at 0.0 (Q1 2022), 0.0 (Q4 2021), and 0.0 (Q3 2021).

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	0.60
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	0.47
7	Evaxion A	62.56 Bn	62.54 Bn	-	0.29
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	0.37
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	0.85
10	Savara	1.30 Bn	1.30 Bn	-	-

Download Data 🔒